THE Generic and Biosimilar Medicines Association (GBMA) has announce the appointment of Arrotex Pharmaceuticals Chief Commercial Officer, Lisa Golden, as the newest member of its board today.
Golden will bring more than 15 years' experience in the pharmaceutical industry across originator and generic brands to the organisation.
She will represent Apotex on the board, while Arrotex CEO, Dennis Bastas will continue to represent Arrow Pharmaceuticals, with the two companies remaining separate entities after the merger earlier this year.
The GBMA board also comprises of representatives of Mylan Australia, Juno Pharmaceuticals, Sandoz Australia and Southern Cross Pharmaceuticals.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Sep 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Sep 19
